Photo: Tyler Patchen for Endpoints News
November 1, 2022 06:00 AM EDTUpdated 02:02 PM
Manufacturing

#CPHI22: Sup­ply chain woes are still bear­ing down on man­u­fac­tur­ers

Tyler Patchen

News Reporter

It’s no se­cret that the wider events in the glob­al land­scape, such as the lin­ger­ing ef­fects of Covid-19 as well as the on­go­ing con­flict in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times